Poster 2013
A. Rohe, C. Henze, F. Erdmann, W. Sippl, M. Schmidt.
A fluorescence anisotropy based Myt1 kinase binding assay
DPhG Annual Meeting 2013
9.–11.10.2013, Freiburg
T. Heimburg; J. Melesina; A. Walter, A.-T. Hauser, K. Schmidtkunz, M. Marek, C. Romier, R. Pierce, M. Schmidt, M. Jung, W. Sippl
Development of benzhydroxamic acids as small molecule inhibitors against smHDAC8 for the treatment of schistosomiasis
DPhG Annual Meeting 2013
09.10.-11.10.2013, Freiburg
B.Sauer, D. Robaa, T. Wagner, M. Jung, M. Schmidt, W. Sippl.
Synthesis of Bisamidines as PRMT Inhibitors
DPhG Annual Meeting 2013
09.-11.10.2013, Freiburg
Karaman B., Huber K., Schröder C., Schemis J., Poschenrieder H., Jung M., Bracher F., and Sippl W.
3,5-Bisarylidene-pyrrolidine-2,4-diones as Novel Inhibitors of Sirtuins
CECAM Workshop “Innovative Approaches to Computatıonal Drug Discovery”
01.-04.10.2013, Laussane, Switzerland
I. Slynko, T. Rumpf, E. Metzger, R. Schüle, M. Jung, W. Sippl.
Rescoring of docking poses using MM-GBSA and QM/MM-GBSA – Predicting biological activities of novel PRK1 kinase inhibitors
CECAM Workshop “Innovative Approaches to Computational Drug Discovery”
01.-04.10.2013, Lausanne, Switzerland
M. Scharfe, M. Pippel, B. Maurer, M. Jung, G. Wolber, W. Sippl.
Structure-based virtual screening for Sirtuin-5 inhibitors
Summer School of Drug Design, University of Vienna
15.-20.09.2013, Vienna, Austria
J. Melesina, T. Heimburg, K. Wichapong, M. Schmidt, A. Hauser, C. Romier, R. Pierce, M. Jung, W. Sippl
Homology modeling of human parasites histone deacetylases
7th Summer School on Drug Design
15.-20.09.2013, Vienna, Austria
T. Uengwetwanit, W. Sippl
Evaluating molecular dynamics simulation for predicting binding affinity changes upon single point mutation: a case study on non-nucleoside HCV NS5B inhibitors
Drug design 2013 ‘Fragment and ligand based drug design’
3.-5.09.2013, Oxford
M. Scharfe, M. Pippel, B. Maurer, M. Jung, G. Wolber, W. Sippl.
Structure-based virtual screening for Sirtuin-5 inhibitors
6th Joint Sheffield Conference on Cheminformatics, University of Sheffield
22.-24.07.2013, Sheffield, UK
J. Melesina
Comparative analysis of histone deacetylase structures of human parasites
33rd European School of Medicinal Chemistry
07.-12.07.2013, Urbino
T. Uengwetwanit, W. Sippl
Improving virtual screening hit identification of HCV NS5B inhibitors by random forest classification
RICT 2013 ‘Drug discovery and selection: When chemical biology meets drug design’
3.-5.07.2013, Nice
I. Slynko, T. Rumpf, E. Metzger, R. Schüle, M. Jung, W. Sippl.
Combination of ligand- and structure-based approaches for searching novel PRK1 kinase inhibitors
EuroCUP VI, OpenEye's 6th annual European science meeting
15.-17.05.2013, Santpoort, Netherlands
Lancelot J, Caby S, Trolet J, Schultz J, Sippl W, Jung M, Marek M, Romier C,
Pierce RJ
Schistosoma mansoni Sirtuins: SmSirt2 is a promising target for drug development against schistosomiasis
Brithish Society for Parasitology 2013 Meeting,
8-11th April 2013, Bristol, UK
Karaman B., Huber K., Schröder C., Schemis J., Poschenrieder H., Jung M., Bracher F., and Sippl W.
3,5-Bisarylidene-pyrrolidine-2,4-diones as Novel Inhibitors of Sirtuins
BAU International Drug Design Symposium 2013
21-23 March 2013, Istanbul, Turkey